Synergistic Activity of Ceragenins Against Carbapenem-Resistant Acinetobacter baumannii Strains in Both Checkerboard and Dynamic Time-Kill Assays

被引:12
|
作者
Bozkurt-Guzel, Cagla [1 ]
Inci, Gozde [2 ]
Oyardi, Ozlem [1 ]
Savage, Paul B. [3 ]
机构
[1] Istanbul Univ, Dept Pharmaceut Microbiol, Fac Pharm, Istanbul, Turkey
[2] Hallym Univ, Dept Biochem, Coll Med, Chunchon 200702, Gangwon Do, South Korea
[3] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA
关键词
COLISTIN; CSA-13;
D O I
10.1007/s00284-020-01949-w
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Acinetobacter baumannii is an emerging opportunistic pathogen that primarily infects critically ill patients in nosocomial settings and there is a need for identifying new alternative therapeutic agents against these organisms. Ceragenins are non-peptide, membrane-active agents that mimic the antimicrobial properties of antimicrobial peptides (AMPs) and affect the membrane permeability of microorganisms. The in vitro activities of CSA-8, CSA-13, CSA-44, CSA-131, CSA-138 either alone or in combination with colistin (sulphate) were determined against 25 carbapenem-resistant A. baumannii strains. Minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) of selected ceragenins and colistin against these isolates were measured by in vitro microbroth dilution techniques. Checkerboard techniques and time-kill assays were performed to determine the activities of combinations. The MIC50 values (mg/L) of CSA-8, CSA-13, CSA-44, CSA-131, CSA-138 and colistin were 32, 4, 8, 2, 4 and 0.5, respectively. The MIC90 (mg/L) of CSA-8, CSA-13, CSA-44, CSA-131, CSA-138 and colistin were 128, 8, 16, 8, 16 and 16, respectively. At 6 h, 1xMIC and 2xMIC of CSA-13 were bactericidal. CSA-13 + colistin combination displayed synergistic interaction. Antagonism between antimicrobials was not observed. According to the results, CSA-13 and CSA-131 can be good alternatives for infections caused by carbapenem-resistant A. baumannii.
引用
收藏
页码:1419 / 1428
页数:10
相关论文
共 50 条
  • [1] Investigation of the Synergic Effect of the Colistin/Sulbactam Combination in Carbapenem-Resistant Acinetobacter baumannii complex Strains with Time-Kill and Checkerboard Methods
    Kilbas, Imdat
    Hatipoglu, Huseyin
    Kilic, Umit
    Kahraman Kilbas, Elmas Pinar
    Koroglu, Mehmet
    Altindis, Mustafa
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2021, 26 (01): : 151 - 162
  • [2] In Vitro and In Vivo Activity of AS101 against Carbapenem-Resistant Acinetobacter baumannii
    Yang, Tsung-Ying
    Tseng, Sung-Pin
    Dlamini, Heather Nokulunga
    Lu, Po-Liang
    Lin, Lin
    Wang, Liang-Chun
    Hung, Wei-Chun
    PHARMACEUTICALS, 2021, 14 (08)
  • [3] In Vitro Activity of Fusidic Acid-Containing Combinations against Carbapenem-Resistant Acinetobacter baumannii Clinical Strains
    Bowler, Sarah L.
    Spychala, Caressa N.
    McElheny, Christi L.
    Mettus, Roberta T.
    Doi, Yohei
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (08) : 5101 - 5101
  • [4] In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates
    Seifert, Harald
    Mueller, Carina
    Stefanik, Danuta
    Higgins, Paul G. G.
    Wohlfarth, Esther
    Kresken, Michael
    ANTIBIOTICS-BASEL, 2023, 12 (07):
  • [5] In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii
    Karaoglan, Ilkay
    Zer, Yasemin
    Bosnak, Vuslat Kecik
    Mete, Ayse Ozlem
    Namiduru, Mustafa
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2013, 41 (06) : 1830 - 1837
  • [6] Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant Acinetobacter baumannii
    Karruli, Arta
    Migliaccio, Antonella
    Pournaras, Spyros
    Durante-Mangoni, Emanuele
    Zarrilli, Raffaele
    ANTIBIOTICS-BASEL, 2023, 12 (12):
  • [7] New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections
    Isler, Burcu
    Doi, Yohei
    Bonomo, Robert A.
    Paterson, David L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (01)
  • [8] Can Drug Repurposing be Effective Against Carbapenem-Resistant Acinetobacter baumannii?
    Lacerda Gontijo, Aline Vidal
    Pereira, Sharlene Lopes
    Bonfante, Herval de Lacerda
    CURRENT MICROBIOLOGY, 2022, 79 (01)
  • [9] Evaluation of the Synergistic Antibacterial Effects of Fosfomycin in Combination with Selected Antibiotics against Carbapenem-Resistant Acinetobacter baumannii
    Nwabor, Ozioma F.
    Terbtothakun, Pawarisa
    Voravuthikunchai, Supayang P.
    Chusri, Sarunyou
    PHARMACEUTICALS, 2021, 14 (03) : 1 - 18
  • [10] In Vitro Antibiotic Synergy in Extensively Drug-Resistant Acinetobacter baumannii: the Effect of Testing by Time-Kill, Checkerboard, and Etest Methods
    Tan, Thean Yen
    Lim, Tze Peng
    Lee, Winnie Hui Ling
    Sasikala, Suranthran
    Hsu, Li Yang
    Kwa, Andrea Lay-Hoon
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (01) : 436 - 438